Should I Buy FN? FN 2026 Analysis

Should You Buy Fabrinet (FN) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion

Buy

Latest Price

498.440

1 Day change

0.44%

52 Week Range

531.220

Analysis Updated At

2026/01/28

BUY for a beginner long-term investor right now. FN is in a clear uptrend (bullish moving averages and expanding positive MACD), institutions/hedge funds have been increasing buying sharply, and the latest quarter showed strong revenue/EPS growth tied to datacom/AI infrastructure demand. Even though the stock is near a key resistance zone (~511) and options positioning shows mild hedging, the overall setup still favors owning shares now (ahead of the 2026-02-02 earnings catalyst) rather than waiting for a perfect pullback.

Technical Analysis

Trend is bullish. Price ~501.5 is above key moving averages with SMA_5 > SMA_20 > SMA_200, signaling a sustained uptrend. MACD histogram (+1.378) is above zero and expanding, supporting continued momentum. RSI_6 ~65.5 is elevated but not extreme, consistent with a strong trend rather than an immediate reversal signal. Key levels: Support at Pivot ~484.8 (then S1 ~458.6). Resistance at R1 ~511.0 (then R2 ~527.2). With price below R1, a push through ~511 would be technically constructive; a dip toward ~485 would be the first notable support test. Pattern-based short-horizon odds suggest modest upside over a week but potential softness over a month, implying some near-term chop is possible even within a longer-term uptrend. Intellectia Proprietary Trading Signals - [AI Stock Picker](module://ai_stock_pick): no signal on given stock today. - [SwingMax](module://swingmax): No signal on given stock recently.

Options Data

Bearish

Open Interest Put-Call Ratio

Bullish

Option Volume Put-Call Ratio

Options sentiment is mixed/neutral. Open interest put-call of 1.09 suggests slightly more puts outstanding (some hedging/caution). Volume put-call of 0.92 is slightly call-leaning on the day (not strongly bullish, but not risk-off). Implied volatility (30d) ~58.3 with IV percentile ~68.8 indicates options are relatively expensive versus the past year range, consistent with a market pricing in a meaningful move (notably with earnings on 2026-02-02 after hours). Overall: mild hedging but no panic; traders are positioning for movement rather than a one-direction bet.

Technical Summary

Sell

Buy

Positive Catalysts

Earnings catalyst: QDEC 2025 earnings on 2026-02-02 (after hours) with Street EPS est. ~3.10—another beat/raise could extend the uptrend.
Fundamental demand tailwinds: analyst commentary highlights AI infrastructure/data center optics and broadening supply chain strength.
Smart-money behavior: Hedge funds are reportedly buying with a large quarter-over-quarter increase in buying activity.
Technical momentum: bullish MA stack and expanding MACD support trend continuation if resistance (~
breaks.

Neutral/Negative Catalysts

Margin pressure: gross margin declined YoY (11.9%, down ~3.33% YoY), which can cap valuation expansion if it persists.
Near resistance: price is approaching R1 (~511); failure to break could lead to a pullback toward ~
Event risk around earnings: options are pricing a sizable move; a guide-down could trigger a sharp drop.
Options positioning shows mild hedging (OI put-call > 1), suggesting some investors are protecting downside.

Financial Performance

Latest quarter (2026/Q1): strong growth. Revenue rose to $978.1M (+21.62% YoY), net income to $95.9M (+23.95% YoY), and EPS to $2.66 (+24.88% YoY). The key blemish is profitability efficiency: gross margin fell to 11.9% (down ~3.33% YoY). Net: growth is robust and accelerating, but margin trends should be watched because they can influence how the market values that growth.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

Recent Street trend is improving, with multiple upward price target moves and Positive/Outperform tones. Susquehanna initiated Positive at $550 (2025-12-15) and later raised to $570 (2026-01-22). Northland reiterated Outperform and raised target to $550 (2025-11-04). Barclays raised its target sharply to $499 but kept Equal Weight (2025-11-05), representing the more cautious view. Wall Street pros: strong execution, accelerating/broad-based growth, and leveraged exposure to datacom/AI infrastructure optics. Wall Street cons: valuation premium risk after strong run and sensitivity to margins/component dynamics; some peers are viewed as having higher earnings growth (Citi commentary comparing to Celestica). Politicians/congress: No recent congress trading data available; insider trend is neutral with no significant recent activity.

6 Analyst Rating

Wall Street analysts forecast FN stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for FN is 544.83 USD with a low forecast of 499 USD and a high forecast of 600 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

5 Buy

1 Hold

0 Sell

Strong Buy

Current: 496.260

Low

499

Averages

544.83

High

600

Current: 496.260

Low

499

Averages

544.83

High

600

Susquehanna

Positive

maintain

$550 -> $570

AI Analysis

2026-01-22

Reason

Susquehanna

Price Target

$550 -> $570

AI Analysis

2026-01-22

maintain

Positive

Reason

Susquehanna raised the firm's price target on Fabrinet to $570 from $550 and keeps a Positive rating on the shares. The firm updated targets in the semiconductor group as a part of an earnings preview. Susquehanna generally expects in-line results to modest upside in Q4, amid a "steadying upcycle" and a broadening of the artificial intelligence infrastructure supply chain. While the industrial end market is improving, auto remains somewhat challenged, the analyst tells investors in a research note.

Keefe Bruyette

Outperform

maintain

$70 -> $72

2025-12-18

Reason

Keefe Bruyette

Price Target

$70 -> $72

2025-12-18

maintain

Outperform

Reason

Keefe Bruyette raised the firm's price target on Fidelity National to $72 from $70 and keeps an Outperform rating on the shares. The firm remains reasonably constructive on the mortgage insurers given the expectation that the companies will generate double-digit book value growth, the analyst tells investors in a research note.

Unlock Full Analyst Thesis， Get the complete breakdown of rating reason for FN

Unlock Now

FN Should I Buy

FN Should I Buy

Should You Buy Fabrinet (FN) Today? Analysis, Price Targets, and 2026 Outlook.

Technical Analysis

Options Data

Technical Summary

Positive Catalysts

Neutral/Negative Catalysts

Financial Performance

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

People Also Watch